Dear Reader,
This year has turned out differently than almost anyone could have imagined. In the midst of change and uncertainty our health can be placed in jeopardy from several fronts both acute and chronic. At ALP Life Sciences we remain dedicated to helping people enhance and protect their health. One-way to be proactive is through reducing ones risk of chronic inflammatory diseases. The CDC stated the following:
“Six in ten Americans live with at least one chronic disease, like heart disease and stroke, cancer, or diabetes. These and other chronic diseases are the leading causes of death and disability in America, and they are also a leading driver of health care cost.”
Furthermore, the CDC explains that individuals with underlying conditions are at higher risks for COVID 19 and they state those are,
“People of all ages with underlying medical conditions, particularly if not well controlled, including
- People with chronic lung disease or moderate to severe asthma
- People who have serious heart conditions
- People who are immunocompromised
- People with severe obesity (BMI of 40 or>)
- People with diabetes
- People with chronic kidney disease undergoing dialysis
- People with liver disease”
According to the National Institutes of Health Omega 3 fatty acids primarily in fish oils have shown to be beneficial in preventing chronic inflammatory disease like “coronary heart disease, hypertension, type 2 diabetes, renal disease, rheumatoid arthritis, ulcerative colitis, Crohn’s disease, and chronic obstructive pulmonary disease.”
Therefore, we recommend you keep supplementing with ALP High-3 to receive the maximum benefit from your omega 3 supplement and reduce your risk of chronic inflammatory diseases.
Stay safe and stay well.
Sincerely,
Robert A. Barker, MD
